Medication info
CMT Tablet (Cimetidine)

CMT Tablet (Cimetidine)

Prescription medicationTablet
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
Light green round film-coated tablet
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 201402013 · Approved 2014.04.25

Summary

Main use
Treatment of acid-related disorders (such as ulcers and gastroesophageal reflux disease) and improvement of gastric mucosal lesions in gastritis
Who uses it
Adults · Children
Adult dosage
Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased in some patients; in such cases, do not increase the dose per administration, but increase the frequency of administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. Depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often if necessary, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to the minimum necessary based on the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis is completed, administer the medicine again according to the schedule. The dose may be adjusted as appropriate according to age and symptoms.
Children's dosage
Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers and gastroesophageal reflux disease) and improvement of gastric mucosal lesions in gastritis

  • Gastric ulcer
  • duodenal ulcer
  • gastroesophageal reflux disease
  • recurrent ulcer
  • anastomotic ulcer
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medication is used for ulcers occurring in the stomach and duodenum, gastroesophageal reflux disease, recurrent ulcers, ulcers at surgical anastomosis sites, and Zollinger-Ellison syndrome. It also helps improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling during acute exacerbations of acute gastritis and chronic gastritis. Overall, it protects the gastric mucosa and alleviates symptoms of gastrointestinal diseases, effectively improving the patient's symptoms.

Dosage and Administration

Adult dosage

Adults: Administer 400 mg of cimetidine orally twice daily (in the morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg orally 4 times daily (after meals and at bedtime). The dose may be increased to 400 mg 4 times daily (after meals and at bedtime) (total 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) associated with the following conditions—acute gastritis and acute exacerbation of chronic gastritis—administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed to relieve pain. The dose may be increased in some patients; in such cases, do not increase the dose per administration, but increase the frequency of administration. Do not exceed 2.4 g per day. Patients with renal impairment: Administer 300 mg of this medicine twice daily, every 12 hours. Depending on the patient's symptoms, the frequency may be increased to 3 times daily, every 8 hours, or more often if necessary, but use caution. In patients with severe renal impairment, the medicine may accumulate in the body; therefore, reduce the frequency of administration to the minimum necessary based on the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis is completed, administer the medicine again according to the schedule. The dose may be adjusted as appropriate according to age and symptoms.

Children's dosage

Administer 20 〜 40 mg per kg of body weight per day orally in divided doses.

Precautions

This medication contains the ingredient cimetidine and should be avoided in certain patients. It should not be administered to patients with a history of allergic reactions to cimetidine or other components of this medication, and should not be used in patients taking dofetilide due to increased risk of cardiac arrhythmia. Patients with impaired renal function, poor liver function, history of drug allergy, elderly patients, children under 19 years of age, and patients undergoing hemodialysis should use this medication cautiously. Especially in renal impairment patients, drug concentration may increase, necessitating dosage reduction or increased dosing intervals, and it is advisable to administer the drug after dialysis for patients on hemodialysis. This medication may mask symptoms of stomach cancer, so it should only be used after confirming it is not due to gastric cancer, and patients with Helicobacter pylori-associated gastric or duodenal ulcers require bacterial eradication therapy. Various side effects such as leukopenia, liver function abnormalities, kidney problems, allergic reactions, gynecomastia, dyspepsia, neuropsychiatric symptoms, cardiac rhythm abnormalities, and severe skin reactions may occur while taking this medication, so it is important to consult a doctor immediately if any abnormal symptoms arise. In particular, elderly patients or those with impaired renal function may more easily exhibit neuropsychiatric symptoms such as confusion or seizures, so caution is needed. This medication may interact with many others; therefore, dosage adjustments or cessation may be needed when taken with warfarin, midazolam, diazepam, propranolol, theophylline, phenytoin, certain antibiotics, and antifungal agents. Pregnant women or those who may become pregnant should only use this medication when the therapeutic effects outweigh the risks, as its safety has not been established; moreover, this medication crosses the placenta and is excreted in breast milk, so caution is warranted during breastfeeding. The safety of this medication in children has not been fully confirmed, so it should be used only when necessary, and elderly patients should use caution as drug concentrations may increase due to impaired renal function, necessitating dosage reduction or increased dosing intervals. Overdose may lead to severe symptoms such as respiratory depression and may require emergency treatment such as mechanical ventilation or gastric lavage. This medication should be kept out of reach of children and transferring it to other containers may pose a risk of accidents and may compromise quality, so caution is advised. Finally, this medication should be used at the minimal effective dose while observing the patient's condition, and if no effect is seen, it is advisable to switch to other treatment methods. Regular blood tests and liver and kidney function tests should be conducted to monitor for abnormalities.

Side effects

  • Leukopenia
  • granulocytopenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • autoimmune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
Show 47 more
  • elevated ALT
  • perivenous liver fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • shock
  • anaphylactoid reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • hypersecretion of milk
  • increased leukorrhea
  • erectile dysfunction
  • abdominal distension
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb numbness
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • weakness
  • altered consciousness
  • confusion
  • bradycardia
  • tachycardia
  • palpitations
  • atrioventricular block
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • desquamative dermatitis
  • generalized exudative erythema
  • fatigue
  • fever
  • systemic heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • alopecia
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in an airtight container that is well-sealed, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Light green round film-coated tablet

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.